SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOctopus Ap Regulatory News (OAP3)

Share Price Information for Octopus Ap (OAP3)

Share Price is delayed by 15 minutes
Get Live Data
45.70    0.00 (0.00%)
Bid:
44.20
Ask:
47.20
Spread: 3.00 (6.787%)
Market Cap: £542.23m
OAP3 Live PriceLast checked at - London Stock Exchange

Intraday Octopus Ap Share Chart

Board Changes

15 Sep 2025 14:00

Board Changes

Octopus Apollo VCT plc

Board Changes

Octopus Apollo VCT plc (‘the Company’) is delighted to announce the appointments of Lindsay Dodsworth and Graeme Gunn as independent non-executive directors of the Company with effect from 15 September 2025.

Lindsay is an experienced non-executive director and a charity trustee. A former partner at EY and non-executive director of Mobeus Income & Growth 4 VCT, Lindsay is currently a non-executive director on the Boards of the Franklin Global Trust, Elveden Farms Ltd, Chair of Governors of St. John’s College School in Cambridge and a Trustee on the Boards of Goodenough College and the Royal Philharmonic Orchestra. Lindsay was for 21 years the Director of a Family Office which had a strong focus on venture and growth capital. Lindsay has an MA from Cambridge University and qualified as a chartered accountant at what is now part of PWC.

Graeme was a founding Partner of SL Capital Partners, a private markets investment firm, a joint venture with what is now Aberdeen Investments, focused on venture capital, private equity, infrastructure and secondary transactions. Since 2019 he has been a Director at 3 Bridges Capital, an M&A advisory business. Graeme is the Chairman of the TravelTech business Maison Sport and is also a non-executive director of Cypress Creek Private Strategies, a US based investment fund focused on private equity and real assets. Graeme is a Chartered Accountant, qualifying with what is now a part of PWC and holds a MEng degree from Edinburgh University.

Lindsay and Graeme will become members of the Audit & Risk Committee, Management Engagement Committee and Nomination & Remuneration Committee of the Company, with effect from the date of their appointment. Neither Lindsay nor Graeme currently have any interest in the ordinary shares of the Company.

There is no additional information required to be disclosed pursuant to UKLR 6.4.8R in relation to the appointments.

Furthermore, the Company announces that Claire Finn has resigned from the Board. Claire will step down in October 2025 following the completion of the half year results process.

 Murray Steele, Chair of Octopus Apollo VCT plc said:

“We are delighted to welcome Lindsay and Graeme and know that they will make a great contribution to the Board. We look forward to benefitting from their wealth of experience. I would also like to thank Claire on behalf of the Board and shareholders for her contribution to Apollo since her appointment to the Board in September 2021.”

For further information please contact:

Rachel Peat Octopus Company Secretarial Services Limited Tel: +44 (0)80 0316 2067

LEI: 213800Y3XEIQ18DP3O53

Date   Source Headline
9th Jun 20263:45 pmBUSPublication of Supplementary Prospectus
8th Jun 202610:20 amBUSAdmission of Further Securities to Trading
8th Jun 202610:15 amBUSAdmission of Further Securities to Trading
8th Jun 202610:00 amBUSAnnual Report for the year ended 31 January 2026 and Notice of Meeting
1st Jun 20267:00 amBUSTotal Voting Rights and Capital
26th May 20264:05 pmBUSIssue of Equity and Total Voting Rights
26th May 20264:00 pmBUSIssue of Equity and Total Voting Rights
22nd May 20265:25 pmBUSFinal Results
1st May 20267:00 amBUSTotal Voting Rights and Capital
20th Apr 20269:00 amBUSRe-Opening of Offer for Subscription to Further Applications
15th Apr 202610:35 amBUSAdmission of Further Securities to Trading
15th Apr 202610:30 amBUSAdmission of Further Securities to Trading
13th Apr 20264:00 pmBUSPurchase of Own Securities and Total Voting Rights
7th Apr 20267:01 amBUSDIRECTOR / PDMR NOTIFICATION
7th Apr 20267:00 amBUSIssue of Equity and Total Voting Rights
2nd Apr 20264:00 pmBUSClose of Offer to New Applications
1st Apr 20267:00 amBUSTotal Voting Rights and Capital
27th Mar 202612:00 pmBUSIssue of Equity and Total Voting Rights
24th Mar 20262:00 pmBUSUpdate on offer for subscription
24th Mar 20267:00 amBUSNet Asset Value and Dividend Declaration
2nd Mar 20267:00 amBUSTotal Voting Rights and Capital
2nd Feb 20267:00 amGNWTotal Voting Rights and Capital
2nd Jan 20267:00 amRNSTotal Voting Rights and Capital
2nd Jan 20267:00 amGNWTotal Voting Rights and Capital
22nd Dec 20253:10 pmRNSDIRECTOR / PDMR NOTIFICATION
22nd Dec 20253:10 pmGNWDIRECTOR / PDMR NOTIFICATION
22nd Dec 20253:05 pmRNSIssue of Equity and Total Voting Rights
22nd Dec 20253:05 pmGNWIssue of Equity and Total Voting Rights
22nd Dec 202510:45 amRNSDIRECTOR / PDMR NOTIFICATION
22nd Dec 202510:45 amGNWDIRECTOR / PDMR NOTIFICATION
22nd Dec 202510:40 amRNSIssue of Equity and Total Voting Rights
22nd Dec 202510:40 amGNWIssue of Equity and Total Voting Rights
2nd Dec 20254:40 pmGNWPurchase of Own Securities and Total Voting Rights
2nd Dec 20257:05 amGNWDIRECTOR / PDMR NOTIFICATION
2nd Dec 20257:00 amGNWIssue of Equity and Total Voting Rights
1st Dec 20257:00 amGNWTotal Voting Rights and Capital
3rd Nov 20257:00 amGNWTotal Voting Rights and Capital
31st Oct 20255:15 pmGNWPurchase of Own Securities and Total Voting Rights
30th Oct 202512:10 pmGNWPublication of Prospectus
15th Oct 20259:00 amGNWBoard Changes
15th Oct 20258:30 amGNWStatement regarding Intention to Launch Offer for Subscription
14th Oct 20254:30 pmGNWHalf-Yearly Results
3rd Oct 20257:00 amGNWNet Asset Value(s)
1st Oct 20257:00 amGNWTotal Voting Rights and Capital
15th Sep 20252:00 pmGNWBoard Changes
1st Sep 20257:00 amGNWTotal Voting Rights and Capital
1st Aug 20257:00 amGNWTotal Voting Rights and Capital
11th Jul 202510:00 amGNWIntention to Fundraise
10th Jul 20254:10 pmGNWResults of Annual General Meeting
1st Jul 20257:00 amGNWTotal Voting Rights and Capital

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.